Study of FHIT transcripts in normal and malignant breast tissue

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The 3p14.2 chromosome subband is implicated in human cancer pathogenesis.
• The fragile histidine triad (FHIT) gene, located at 3p14.2, is a candidate tumor suppressor gene.
• Previous studies reported abnormal FHIT transcripts in various tumors, including breast cancer, but findings were inconsistent.

Purpose of the Study:

• To investigate the role of FHIT gene transcripts in breast tumorigenesis.
• To clarify discrepancies regarding FHIT's involvement in cancer development.
• To analyze FHIT transcript variants in normal and malignant breast tissues.

Main Methods:

• Analysis of FHIT gene transcripts using single-stage and nested PCR strategies.
• Examination of 27 normal and 33 malignant breast tissue samples.
• Quantification of variant FHIT transcripts relative to wild-type levels.

Main Results:

• Multiple variant FHIT transcripts were detected at very low levels (<1% of wild-type).
• These variant transcripts were present in the majority of breast tumors.
• Variant transcripts were also found in adjacent normal breast tissues and in normal breast tissue from healthy women.

Conclusions:

• The presence of variant FHIT transcripts in both normal and cancerous breast tissues does not support FHIT's role as a tumor suppressor in breast cancer.
• Observed FHIT transcript variations are likely due to alternative splicing in normal tissues, not cancer-specific events.
• Further research is needed to fully understand FHIT gene function and alternative splicing in various tissues.